Monoclonal Antibodies Provide Small Benefits in Alzheimer Disease
FRIDAY, Jan. 26, 2024 -- Monoclonal antibodies targeting amyloid provide small benefits on cognitive and functional scales, which do not meet the minimal clinically important difference, according to a review published in the January/February issue...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Alzheimer's | Pharmaceuticals